BSE filing, NSE: NIDHGRN. Summary written from the filing by ALFA Finder's alert engine.
Nidhi Granites Ltd: key numbers
- Share price
- ₹242.00
- Market cap
- ₹193.6 Cr
- Revenue (annual)
- ₹65.20 Cr
- Net profit (annual)
- ₹7.68 Cr
- P/E (TTM)
- 23.2×Sector 31.7×
- Promoter holding
- 66.75%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nidhi Granites Ltd
All →Nidhi Granites Acquisition
Nidhi Granites subscribed to Jowela Exim's rights issue, acquiring 16,00,000 equity shares. This makes Jowela Exim a subsidiary of Nidhi Granites.
Nidhi Granites Acquisition Worth ₹1.6 Cr
Nidhi Granites Ltd will acquire a 50.50% controlling stake in Jowela Exim Private Limited for ₹1.60 Crore, making it a subsidiary.
- Value
- ₹1.60 Cr
- Execution
- by October end
Nidhi Granites Q1 FY27 Results: Net Profit ₹2.9 Cr, Up 31.8% YoY
Nidhi Granites Ltd reported revenue from operations of ₹15.8 Cr (-20.2% YoY) and net profit of ₹2.9 Cr (+31.8% YoY) for Q1 FY27.
- Key figure
- Net profit ₹2.9 Cr · +31.8% YoY
Nidhi Granites Board Meeting Date
Nidhi Granites Limited scheduled a board meeting for August 13, 2026, to consider quarterly financial results. The trading window remains closed until August 16, 2026.
Nidhi Granites Annual General Meeting
Nidhi Granites Ltd held its 44th Annual General Meeting on July 22, 2026. The meeting covered financial statements, director appointments, and auditor re-appointments.
Nidhi Granites Annual General Meeting
Nidhi Granites Ltd will hold its 44th Annual General Meeting on 22 July 2026 via video conferencing. The meeting will consider audited financial statements and director re‑appointment.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.